• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule.

出版信息

Fed Regist. 1981 Jan 2;46(1):28.

PMID:10249520
Abstract

The Food and Drug Administration (FDA) amends its patient package insert regulations to list ampicillin and phenytoin as drugs that must be dispensed with patient package inserts. The ampicillin patient package insert applies to drug products containing amoxicillin, ampicillin, or hetacillin. Elsewhere in this issue of the Federal Register, FDA announces the availability of final guideline patient package inserts for ampicillin and phenytoin and applies the agency's patient package insert regulations to them.

摘要

相似文献

1
Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule.
Fed Regist. 1981 Jan 2;46(1):28.
2
Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice.处方药;最终指南患者用药指导说明书的撤销及指南患者用药指导说明书草案的撤回——美国食品药品监督管理局。通知。
Fed Regist. 1982 Sep 7;47(173):39249-50.
3
Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.处方药产品;患者用药指导手册要求——食品药品监督管理局。最终规则。
Fed Regist. 1981 Jan 2;46(1):28-30.
4
Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.食品药品监督管理局——处方药产品;患者用药指导手册要求。最终规则。
Fed Regist. 1980 Sep 12;45(179 Pt 2):60754-84.
5
Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.处方药产品;患者用药指导手册要求的撤销——食品药品监督管理局。最终规则。
Fed Regist. 1982 Sep 7;47(173):39147-55.
6
Institutional pharmacists' guide to complying with PPI regulations.机构药师遵守质子泵抑制剂(PPI)法规指南。
Am J Hosp Pharm. 1980 Dec;37(12):1656-9.
7
Requirements on content and format of labeling for human prescription drug and biological products. Final rule.人用处方药和生物制品标签的内容与格式要求。最终规则。
Fed Regist. 2006 Jan 24;71(15):3921-97.
8
Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule.用于非处方人类使用的防晒药品;最终专论。美国卫生与公众服务部食品药品监督管理局。最终规则。
Fed Regist. 1999 May 21;64(98):27666-93.
9
Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's Syndrome warning. Final rule.含阿司匹林和非阿司匹林水杨酸盐的口服及直肠非处方药品标签;雷氏综合征警示。最终规则。
Fed Regist. 2003 Apr 17;68(74):18861-9.
10
Investigational new drug applications; clinical holds--FDA. Direct final rule.研究性新药申请;临床搁置——美国食品药品监督管理局。直接最终规则。
Fed Regist. 1998 Dec 14;63(239):68676-8.